Grantham, Mayo, Van Otterloo & Co (GMO)
VNDA icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Vanda Pharmaceuticals VNDA Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$113K Buy
+16,322
New +$126K ﹤0.01% 621
2021
Q4 		– Sell
-13,100
Closed -$225K – 739
2021
Q3 		$225K Buy
+13,100
New +$229K ﹤0.01% 661
2021
Q1 		– Sell
-14,600
Closed -$192K – 945
2020
Q4 		$192K Sell
14,600
-122,700
-89% -$1.48M ﹤0.01% 780
2020
Q3 		$1.33M Sell
137,300
-29,300
-18% -$313K 0.01% 471
2020
Q2 		$1.91M Buy
166,600
+146,600
+733% +$1.66M 0.01% 428
2020
Q1 		$207K Buy
+20,000
New +$248K ﹤0.01% 700

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return